Next Article in Journal
Inhibitory Effect of IL-1β on HBV and HDV Replication and HBs Antigen-Dependent Modulation of Its Secretion by Macrophages
Next Article in Special Issue
High-Throughput Platform for Detection of Neutralizing Antibodies Using Flavivirus Reporter Replicon Particles
Previous Article in Journal
Symptom-Based Predictive Model of COVID-19 Disease in Children
Previous Article in Special Issue
First Evidence of West Nile Virus Overwintering in Mosquitoes in Germany
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 14
Issue 1
10.3390/v14010064
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain?

by
Giulia Mencattelli
1,2,3,*,
Federica Iapaolo
1,
Federica Monaco
1,
Giovanna Fusco
4,
Claudio de Martinis
4,
Ottavio Portanti
1,
Annapia Di Gennaro
1,
Valentina Curini
1,
Andrea Polci
1,
Shadia Berjaoui
1,
Elisabetta Di Felice
1,
Roberto Rosà
2,
Annapaola Rizzoli
3 and
Giovanni Savini
1
1
Istituto Zooprofilattico Sperimentale dell’Abruzzo e del Molise, 64100 Teramo, Italy
2
Center Agriculture Food Environment, University of Trento, 38098 Trento, Italy
3
Fondazione Edmund Mach, San Michele all’Adige, 38098 Trento, Italy
4
Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Napoli, Italy
*
Author to whom correspondence should be addressed.
Viruses 2022, 14(1), 64; https://doi.org/10.3390/v14010064
Submission received: 13 November 2021 / Revised: 18 December 2021 / Accepted: 28 December 2021 / Published: 30 December 2021
(This article belongs to the Special Issue Emerging Zoonotic Viral Diseases)
Browse Figures
Review Reports Versions Notes

Abstract

:
In Italy, West Nile virus (WNV) appeared for the first time in the Tuscany region in 1998. After 10 years of absence, it re-appeared in the areas surrounding the Po River delta, affecting eight provinces in three regions. Thereafter, WNV epidemics caused by genetically divergent isolates have been documented every year in the country. Since 2018, only WNV Lineage 2 has been reported in the Italian territory. In October 2020, WNV Lineage 1 (WNV-L1) re-emerged in Italy, in the Campania region. This is the first occurrence of WNV-L1 detection in the Italian territory since 2017. WNV was detected in the internal organs of a goshawk (Accipiter gentilis) and a kestrel (Falco tinnunculus). The RNA extracted in the goshawk tissue samples was sequenced, and a Bayesian phylogenetic analysis was performed by a maximum-likelihood tree. Genome analysis, conducted on the goshawk WNV complete genome sequence, indicates that the strain belongs to the WNV-L1 Western-Mediterranean (WMed) cluster. Moreover, a close phylogenetic similarity is observed between the goshawk strain, the 2008–2011 group of Italian sequences, and European strains belonging to the Wmed cluster. Our results evidence the possibility of both a new re-introduction or unnoticed silent circulation in Italy, and the strong importance of keeping the WNV surveillance system in the Italian territory active.

1. Introduction

West Nile virus (WNV) is a mosquito borne single-stranded RNA virus, a member of the Japanese encephalitis (JE) serocomplex belonging to the genus Flavivirus within the Flaviviridae family [1]. WNV is maintained in nature through an endemic cycle which involves mosquitoes (Diptera; Culicidae) as vectors, and birds as reservoir hosts [2]. Humans and horses are considered “dead-end” hosts: they may develop disease; however, they are not able to infect vectors, and maintain the virus in the environment [3]. To date, eight different lineages of WNV have been described [4]. Lineages 1 and 2, often associated with cases of encephalitis in humans and horses, are by far those most widespread in Europe and the Mediterranean basin [5,6,7,8].
In Europe, WNV lineage 1 (WNV-L1) circulation was first evidenced in the 1960s in France, Portugal, and Cyprus [8,9,10]. Thirty years later, cases associated to WNV-L1 infection were reported in humans and horses in North African, Western, and Eastern European countries [8]. The WNV-L1 strains responsible for the Morocco (1996), Italy (1998), Israel (1998), and France (2000) human and horse cases [11,12,13,14,15,16] grouped into the Western-Mediterranean (WMed) clade, whereas those responsible for the Romanian (1996) and Russian (1999) human cases clustered in the Eastern-European clade [17,18,19]. A strong relationship has been observed between the WNV-L1 Israeli and Northern African strains which emerged in the Mediterranean region in the late 1990s, and the ones responsible for the 1999 New York epidemics, suggesting a viral flow between North Africa and North America via the Middle East [20]. In the early 2000s, WNV-L1 outbreaks were again recorded in Morocco, France, and Romania [16,21,22,23]. Starting from 2005, however, WNV lineage 2 (WNV-L2) strains belonging to the Hungarian and Volgograd clades started spreading to some South-Eastern and Eastern European countries [24,25,26,27,28,29,30]. In some regions, co-circulation of both WNV-L1 and L2 were observed [8,24,29,31,32,33]. Following the WNV-L2 incursions and spread, the circulation of WNV-L1 strains was less frequently observed. From 2010, it was reported in Morocco, Algeria, Tunisia, Spain, and Portugal [34,35,36,37,38,39]. Eastern WNV-L1 strains instead kept circulating in Romania, and spread in Bulgaria and Ukraine [27,40,41]. Human and horse infections with Eastern WNV-L1 strains were also reported in Turkey in 2010 and following years [42,43]. In recent years, WNV-L1 circulation appeared to be limited to Northern African countries, the Iberian Peninsula, Cyprus, Turkey, Israel, and Serbia [36,37,38,39,44,45,46,47,48,49,50].
In Italy, WNV-L1 emerged for the first time in the Tuscany region in 1998 [12,13]. Since then, the Italian Ministry of Health implemented a national veterinary surveillance plan for monitoring WNV in areas at risk of viral introduction and circulation [32]. The surveillance system did not detect any relevant WNV circulation until 2008, when WNV-L1 was identified in mosquitoes, birds, horses, and humans in the area surrounding the Po River delta [51]. Since 2008, WNV epidemics caused by genetically divergent isolates have been registered every year [29,52]. The phylogenetic analysis of the isolates confirmed the hypothesis of the virus overwintering, and the endemization in local host populations [53,54]. Between 2010 and 2011, WNV-L1 circulation further spread into Southern Italy, involving Sicily, Apulia, Calabria, Basilicata, and Sardinia regions [32,52,55]. Partial genome sequencing showed that strains isolated in the same area in 2011 were almost identical, but divergent from those responsible for the outbreak in Northern Italy in 2008–2009 [56,57] which, conversely, appeared strictly related to the WNV strains circulating in Europe and Israel from late 2004 to 2011 [55]. In 2011, WNV-L2 was first reported in Italy [31,58,59]. Since then, WNV-L1 circulation was reported only sporadically in birds and mosquito pools from North-Eastern regions (2012–2014, 2017) and Sardinia (2015–2016) [32]. In Italy, WNV-L1 was last detected in a mosquito pool collected in the Piacenza province in 2017 (https://westnile.izs.it/j6_wnd/wndItalia;jsessionid=D0C9EB639E7C322D0EFC34ECEB8E4D8E, accessed on 14 September 2021). According to a risk-based ranking of the Italian provinces, wild birds, mainly corvids (Eurasian jay, Garrulus glandarius; Carrion crow, Corvus corone; and Magpie, Pica pica), poultry, horses, and mosquitoes, are constantly sampled to obtain an early detection of WNV circulation, and reduce the risk of human transmission. To date, 16 out of the 20 Italian regions are considered endemic (Italian epidemiological reports).
In October 2020, the WNV-L1 strain re-emerged in Italy, notably in the Campania region. Within the wildlife monitoring plan of the Campania region (PGMFS) and the National Plan for Prevention, Surveillance, and Response to Arbovirus 2020–2025, WNV-L1, was detected in two wild birds, a kestrel (Falco tinnunculus) and a goshawk (Accipiter gentilis), found in Naples and Caserta provinces, respectively. This is the first occurrence of WNV-L1 detection in migratory and resident raptor birds since 2018.
In this paper, we describe the two cases, and characterize by whole genome sequencing (WGS) and phylogenetic analysis the WNV-L1 responsible for the goshawk infection.

2. Materials and Methods

2.1. Bird Conditions and Laboratory Analyses

In October 2020, two wild birds, a kestrel and a goshawk, were found in critical conditions in Naples (Somma Vesuviana municipality 40.878958, 14.426694) and Caserta (Trentola Ducenta municipality 40.976368, 14.1664) provinces, respectively (Figure 1). The two birds, immediately transferred to the Regional Center for Wild Animals (CRAS) for rescue operations, died 48 h after the transfer. In detail, at the time of admission at the clinic, the kestrel was in a comatose state showing mydriasis. The radiography also evidenced the fracture of the tibia, and the presence of two bullet fragments. At the time of acceptance, the goshawk showed head injury, head tilt, and right lower limb ataxia. Necropsies were carried out, and selected tissues (heart, kidney, spleen, and brain) were collected, pooled, and homogenized in a sterile phosphate-buffered saline (PBS). Viral RNA was extracted from 200 μL supernatants using Qiasymphony® DSP automatic instrumentation (Germantown, MD, USA) according to the manufacturer’s instructions. Quantitative reverse transcription polymerase chain reactions (qRT PCR) to detect WNV-L1 and/or -L2 RNA was performed at the U.O.C. Virology of IZSM as described by Del Amo and colleagues [60]. The samples were sent to the National Reference Centre for Foreign Animal Diseases (CESME) at the Istituto Zooprofilattico Sperimentale of Abruzzo and Molise in Teramo (IZSAM) for WNV confirmation and further analysis.

2.2. Virus Strain and Laboratory Tests (IZSAM)

Virus RNA of the two samples’ homogenates was extracted at IZSAM by using the MagMAX CORE Nucleic Acid Purification KIT (Applied Biosystem, Thermo Fisher Scientific, Life Technologies Corporation, TX, USA) according to the manufacturer’s instructions. The virus RNA was tested by two qRT-PCR: (i) a 1-step RT- PCR assay for the simultaneous detection of WNV-L1 and 2 strains, by using the QuantiTect Probe RT-PCR Kit (QIAGEN) [60]; and (ii) an RT-PCR assay for detection of all known lineages of West Nile virus [61], by using the Superscript III Platinum OneStep qRT-PCR System (Invitrogen). The RNA detected in the goshawk tissue samples was further fully sequenced by using next generation sequencing (NGS) technology. Briefly, total RNA was treated with TURBO DNase (Thermo Fisher Scientific, Waltham, MA, USA) at 37 °C for 20 min, and then purified by an RNA Clean & Concentrator™-5 Kit (Zymo Research, Irvine, CA, USA). The purified RNA was used for the assessment of sequencing independent single primer amplification protocol (SISPA) [62,63]. In detail, viral RNA underwent cDNA synthesis using 200 units of the SuperScript® IV Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA, USA), in the presence of 5X SSIV Buffer, 50 μM of the random hexamer FR26RV-N 5′-GCCGGAGCTCTGCAGATATCNNNNNN-3′, 10 mM of dNTPs mix, 100 mM of DTT, and 40U of RNAse OUT RNase inhibitor (Thermo Fisher Scientific, Waltham, MA). The reaction was incubated at 23 °C for 10 min, and 50 °C for 50 min. After an inactivation step at 80 °C for 10 min, 12.5 Units of 3′-5′ Klenow Polymerase (New England Biolabs, Ipswich, MA, USA) were directly added to the reaction to perform the second strand cDNA synthesis. The incubation was carried out at 37 °C for 1 h, and 75 °C for 10 min. Next, 5 μL of ds cDNA were added to 45 μL of PCR master mix containing 5X Q5 Reaction Buffer, 10 mM of dNTPs, 40 μM of the random primer FR20 Rv 5′-GCCGGAGCTCTGCAGATATC-3′, Q5® High Fidelity DNA polymerase (NEB, New England Biolabs, Ipswich, MA, USA), and Q5 High Enhancer [64]. The reaction was incubated at 98 °C for 10 s, 65 °C for 30 s, 72 °C for 3 min, and 72 °C for 2 min. The PCR product was purified using the Molecular Biology Kit BioBasic (Biobasic inc., Markham, ON, Canada), and then quantified by using the Qubit® DNA HS Assay Kit (Thermo Fisher Scientific, Waltham, MA, USA). The sample was diluted to obtain a concentration of 100–500 ng, and used for library preparation by using the Illumina DNA Prep kit (Illumina Inc., San Diego, CA, USA) according to the manufacturer’s protocol. Deep sequencing was performed on the NextSeq 500 (Illumina Inc., San Diego, CA, USA) using the NextSeq 500/550 Mid Output Reagent Cartridge v2, 300 cycles, and standard 150 bp paired end reads. FASTQ files were generated using NextSeq Reporter (Illumina). The sequencing run delivered 300 Mb of sequence data. The reads obtained were trimmed using a Trimmomatic script (Trimmomatic v0.36) to remove low quality and short reads [65]. Furthermore, the reads were quality controlled by using FastQC v0.11.5 [63,66]. The resulting 2,149,990 reads were de novo assembled using SPADES v3.11.1 [67]. Based on genome assemblies, a de novo filtering for the scaffolds with a minimum length of 200 nucleotides, and a matching for the best reference for each assembly using ABRicate was carried out [63]. Finally, a mapping with the references found in the previous step using Bowtie2 (v.2.1.0) was performed [68]. The length of the final assembly (GenBank accession number MW627239) was of 10,990 bp, and it showed 98.33% nucleotide identity to the reference sequence FJ483548.

2.3. Phylogenetic Analyses

A total of 64 sequences with information on country and year of isolation were downloaded from Genbank or from the IZSAM database for this study. In particular, the study was conducted using 34 complete genome sequences, 18 polyprotein gene complete coding DNA sequences (cds), and 12 partial cds (polyprotein and envelope glycoprotein gene). Sequences were obtained from mosquitoes (n = 7), birds (n = 24), horses (n = 6), humans (n = 16), and mice (n = 1) (10 sequences were from unknown hosts). They were selected from Italy (n = 27), Portugal (n = 2), France (n = 4), Spain (n = 4), Romania (n = 2), Israel (n = 2), Morocco (n = 2), Nigeria (n = 1), Russia (n = 5), Senegal (n = 3), Cyprus (n = 1), Turkey (n = 1), Japan (n = 1), Americas (n = 7), Kenya (n = 1), and Central African Republic (CAR) (n = 1). With the addition of 1 new sequence, a total of 65 sequences were aligned using the ClustalW algorithm implemented in Ugene v. 37.0 software (available at http://ugene.net/download.html, accessed on 12 August 2021). Aligned sequences were manually curated using BioEdit v. 7.2 software (available at http://www.mbio.ncsu.edu/BioEdit/bioedit.html, accessed on 12 August 2021). Metadata of all sequences referred to in this manuscript can be found in Table 1.
The Bayesian phylogenetic analysis was performed through Bayesian Inference (BI) using a general time-reversible with gamma-distributed rate variation, a gamma category count of 4, and an invariant sites model (GTR + Γ + I), as selected by Akaike’s information criterion (AICc) in jModelTest 0.1 [69]. A Bayesian MCMC approach using BEAST with JRE v2.6.3 was then employed. Ten independent MCMC runs with up to 100 million generations were performed to ensure the convergence of estimates. Tracer v.1.7.1 (available at http://beast.bio.ed.ac.uk/Tracer, accessed on 12 August 2021) was used to ensure convergence during MCMC by reaching effective sample sizes greater than 100. Trees were summarized in a maximum clade-credibility tree with common ancestor heights after a 10% burn-in [69] using TreeAnnotator v.2.6.3. A maximum likelihood tree was estimated using FigTree v1.4.4 [70] after identical alignment and curating methods. FigTree was run using the GTR + Γ + I nucleotide model with 2000 Γ-rate categories, exhaustive search settings, with 5000 bootstrap replications using the Shimodaira–Hasegawa (SH) test. All sequence alignments referred to in this manuscript can be found in Supplementary Materials.

3. Results

3.1. Strain Characterization and Phylogenetic Analysis

3.1.1. WNV-L1 Detection

WNV-L1 was detected and confirmed in both the kestrel and the goshawk organs (heart, kidney, spleen, and brain pooled together in PBS).

3.1.2. Phylogenetic Tree Inferred with Maximum-Likelihood Analysis

Phylogenetic inference of WNV using a maximum-likelihood tree is shown in Figure 2 and Figure 3. All Shimodaira–Hasegawa values are displayed at respective nodes.
According to the analysis, WNV-L1 is represented by three main clusters: (1) the Mediterranean-Eastern European-Kenyan WNV cluster, that includes isolates from Senegal (1993), Kenya (1998), Romania (1996–97), Russia (1999, 2000, 2006), and Cyprus (2016); (2) the WMed cluster, including isolates from Europe (Italy 1998, 2008, 2009, 2011 and 2020; Spain 2007, 2008; Portugal 2004 and 2009; France 2003, 2004 and 2015), Israel 2000–2007, and Morocco 1996–2003; and (3) the Israeli-American WNV cluster, including several American strains, isolated between 1999 and 2002 (all phylogenetically very similar among them), in addition to strains from Japan (2007), Europe (France 2003 and Spain 2007), and Africa (Nigeria 1965, CAR 1967, Senegal 1979, and Tunisia 2011), confirming a WNV clusterization already highlighted in the past [71,72] (Figure 2 and Figure 3).
The genome analysis includes the new strain TE_362447_2020 (accession number: MW627239 lineage 1, Italy, 2020) into the WMed single monophyletic group (Figure 3).
A close similarity is observed between the MW627239 and the 2008–2011 groups of sequences clustered separately into the WMed subtype (Figure 3). Phylogenetically, a similarity is also observed between the Italian WNV-L1 (2008, 2011, 2020) and the viral strains circulating in Europe in the recent past (Spain 2010, France 2015), although they are less temporally close than the Italian strains [71].

3.1.3. Full-Length Polyprotein Sequencing

Using BioEdit v. 7.2 software (available at http://www.mbio.ncsu.edu/BioEdit/bioedit.html, accessed on 12 August 2021), an amino acid sequence comparison between MW627239 and representative WNV-L1 Italian, European, and American isolates was performed. In particular, the strains (i) 115803 (accession number: FJ483548, Italy, 2008); (ii) WNV Italy 1998-equine (accession number: AF404757, Italy, 1998); (iii) Italy/2008/M-203204 (accession number: JF719066, Italy, 2008); (iv) Italy/2008/J-242853 (accession number: JF719065, Italy, 2008); (v) 21412 (accession number: MW835362, Italy, 2011); (vi) Italy/2013/Livenza/35.1 (accession number: KF647253, Italy, 2013); (vii) Spain/2010/H-1b (accession number: JF719069, Spain, 2010); (viii) GE-2o/V (accession number: FJ766332, Spain, 2007); (ix) Akela/France/2015 (accession number: MT863559, France, 2015); and (x) NY99 (accession number: NC009942, USA, 1999) were included in the analysis. Only representative amino acid residues were analyzed [7,52,73,74,75]. Results are shown in Table 2.
Using Blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 12 August 2021), a nucleotide and amino acid pairwise identity analysis was conducted among MW627239 and the Italian, European, and American sequences listed above, as shown in Table 3. Among the Italian representative sequences belonging to the WNV-1 WMed single monophyletic group in the maximum-likelihood tree, the average nucleotide and amino acid pairwise identity was evidenced to be 98.13% (s.d. = 0.36) and 99.73 % (s.d = 0.07), respectively.
Results evidence a close genetic relatedness of the WNV-L1 strain that re-emerged in the Campania region in 2020, and the Italian and European strains belonging to the WNV-L1 WMed sub-cluster.

4. Discussion

This paper reports the first evidence of WNV-L1 strain circulation in the Campania region, Italy. The strain was detected in October 2020 in two wild birds found moribund in nearby areas, only a few days apart. It was the first detection of WNV-L1 after several years. The last WNV-L1 strain circulation evidenced in Italy dates back to 2017, when it was found in a pool of mosquitoes from Northern Italy (https://westnile.izs.it/j6_wnd/wndItalia;jsessionid=D0C9EB639E7C322D0EFC34ECEB8E4D8E, 14 September 2021).
The last evidence of WNV-L1 circulation in an area most nearby the Campania region dates back to 2016 when the circulation of a WNV-L1 strain was responsible for the death of several wild birds in Sardinia [31]. The first question which clearly came to mind when tackling this finding was: “was this strain the result of a new introduction or was it just a re-occurrence of a strain already circulating?”.
The first assumption supposes the virus probably extinguished and reintroduced through migratory birds. The species where the strains were detected did not help in clearing the question. Goshawks and kestrels can in fact be considered either migrant or resident birds. Unfortunately, it was not possible to check the carcasses, and eventually make out the bird behavior from wing, claw, and feather characteristics [74,75,76]. In support of the re-introduction of WNV-L1 is the lack of detection for consecutive years by the national surveillance program, which has been in place since 2002, and has been drawn to detect virus circulation early. In the same way, a phylogenetic relationship (%), and nucleotide and amino acid similarities are observed between the new sequence, MW627239, and some European sequences obtained in the past (Spain 2010, France 2015) (Figure 3, Table 2 and Table 3). This might suggest a possible viral circulation in the Mediterranean followed, by a re-introduction in Italy in 2020.
Still on the phylogenic tree, however, the new strain MW627239 shows high nucleotide sequence identity (%) with the 2008–2011 Italian sub-clusters of the WMed single monophyletic group (Figure 3). In this respect, the second hypothesis, the WNV-L1 re-occurrence, seems to be the most credible scenario. Even if, in all these years, WNV has repeatedly proven its ability to overwinter and become endemic in many Italian regions, silence periods are factually not unusual for WNV-L1 [53,71]. After its first occurrence in the Tuscany region in 1998, WNV re-appeared in the areas surrounding the Po River delta after 10 years [55]. Similarly, in Sardinia, WNV-L1 was not detected for 3 consecutive years between 2011 and 2015 (https://westnile.izs.it/j6_wnd/wndItalia;jsessionid=D0C9EB639E7C322D0EFC34ECEB8E4D8E, 14 September 2021). In this particular case, the WNV-L1 presence was accidentally uncovered in two wild birds when they were in critical conditions. The presence of clinical signs in birds would indeed facilitate the discovery of virus circulation on many occasions, as observed in several WNV epidemics of the early 2000s [16,76,77]. Even though the majority of the WNV infections in birds are usually mild or asymptomatic [78], some species, such as birds of prey, jays, and crows, are highly susceptible, and can develop severe and even fatal encephalitis [78,79,80]. Clinical symptoms associated to WNV-L1 infection have been mainly reported in the orders of Passeriformes (corvids, blue jays, magpies) and Falconiformes (birds of prey) [81,82,83]. Fatal infections have been described in European eagles in Spain [84,85], and geese and poultry in Hungary [24]. The two WNV-L1 infected birds found in Campania were in critical conditions. Though the comatose state of the kestrel was likely the consequence of a gunshot wound, the origin of the clinical picture observed in the goshawks is not easy to assess. Head injury, head tilt, and right lower limb ataxia are definitely signs of neurologic pathology. However, whether these symptoms were a consequence of the head injury or vice versa couldn’t be determined. In nature, goshawks have been shown to be highly susceptible to WNV infection, probably because of their predatory habits [81]. Oral transmission of WNV by feeding on infected prey has been described, and is believed to be an important route of transmission in birds of prey [79,83,86]. Both WNV-L1 and L2 experimental infections conducted in American kestrels (Falco sparverius), golden eagles (Aquila chrysaetos), red-tailed hawks (Buteo jamaicensis), barn owls (Tyto alba), and great horned owls (Bubo virginianus) showed high level of viraemia, and important clinical symptoms, such as lethargy, inappetence, body weight loss, and muscle tremor [82,87,88]. However, looking back over the past 13 years of circulation in Italy, WNV-L1 seems to be unable to cause important clinical manifestations and deaths in birds [52].
The virulence of WNV depends on several factors related to the pathogen, hosts, and their interaction [89,90]. Concerning the pathogen, changes in the amino acid positions may significantly influence the WNV strain virulence [7]. Multiple genetic variations correlated with increased or decreased pathogenicity have been highlighted in genetic and phenotypic studies of WNV mutants [74]. Among the WNV genes, the NS3 helicase domain is considered a virulence determinant [52,91]. In particular, increased avian virulence due to the point mutation NS3-T249P has been reported in American crows (Corvus brachyrhynchos) and in site-directed mutagenesis experiments [73,92,93,94]. In support of our analysis, the Italian strain MW627239 is not characterized by the NS3-T249P point mutation. A threonine residue was observed at the 249 position in the strain MW627239, as well as in JF719065 and MW835362, circulating in Italy in 2008 (jay) and 2011 (owl), and in JF719069 and MT863559, circulating in Spain (horse) and France (human) in 2010 and 2015, respectively. Furthermore, the amino acid valine at the residue 159 of the E protein is considered a determinant of WNV neurovirulence, influencing viral replication and pathogenesis, and being involved in WNV infection and T-cell infiltration in the brain [75]. This amino acid is observed in the isolate NC009942, circulating in the USA in 1999, but not in the Italian and European strains, all characterized by isoleucine at this residue position. This point mutation might also help explain the low pathogenesis observed among birds in Italy and, more generally, in Europe. It is likely that the WNV pathogenicity is the result of a complex series of events which involve the virus, the vectors, and the hosts. Further studies correlated with the WNV genotype and phenotype may help in understanding the mechanisms underlying WNV clinical signs in birds, and the emergence of new pathogenic phenotypes.

5. Conclusions

In recent years, WNV-L2 has been, by far, the most frequent lineage detected in Italy, whereas WNV-L1 was detected only occasionally. Since 2008, about 1500 wild birds and 5000 resident birds belonging to target species (carrion crow, magpie, Eurasian jay) have been annually tested by real time RT-PCR to monitor the circulation of WNV L1 and L2 strains in Italy. Among them, 326 wild birds and 804 target species were found positive to WNV (https://westnile.izs.it/j6_wnd/home, 16 December 2021). Concerning WNV-L1, it was last detected in a sparrow hawk (Accipiter nisus) and in two carrion crows in the Sardinia region during the 2016 vector season.
Serological analysis conducted in Italy on humans and horses between 2008 and 2020 identified anti-WNV-IgM in 1189 persons and 1196 horses. No evidence of WNV circulation was detected in the Campania region [95] (https://westnile.izs.it/j6_wnd/home, 16 December 2021). The detection of the WNV-L1 strain in two wild birds described in this study emphasizes the importance of having in place an efficient surveillance system, and, in particular, the early warning function played by some avian species in detecting WNV circulation.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/v14010064/s1, File S1: WNV Lineage 1 Sequence Alignment.

Author Contributions

Conceptualization, G.M., F.I., G.F., C.d.M. and G.S.; methodology, G.M., F.I. and G.S.; validation, F.M., A.P., V.C. and G.S.; formal analysis, V.C., A.P. and G.M.; investigation, A.D.G., O.P., V.C., A.P., S.B. and G.M.; resources, G.S.; data curation, F.I., V.C., A.P. and G.M.; writing G.S., G.F., C.d.M., F.I. and G.M., original draft preparation, G.F., C.d.M., F.I., G.M. and G.S.; writing—review and editing, F.I., F.M., G.F., C.d.M., V.C., A.P., E.D.F., R.R., A.R., G.M. and G.S.; visualization, G.M., F.I., F.M., G.F., C.d.M., O.P., A.D.G., V.C., A.P., S.B., E.D.F., R.R., A.R. and G.S.; supervision, G.S.; project administration, G.S.; funding acquisition, G.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Italian Ministry of Health, law 19 January 2001. This research was financially supported by an international PhD initiative including Fondazione Edmund Mach, University of Trento, and Istituto Zooprofilattico of Teramo.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Sequence data are available via NCBI. The accession numbers for the sequences used can be found in Table 1.

Acknowledgments

The authors thank Liana Teodori for their excellent technical assistance. The authors acknowledge all personnel in the lab and in the field for their skill and technical support.

Conflicts of Interest

All the authors declare no conflict of interest.

References

  1. Llopis, I.V.; Rossi, L.; Di Gennaro, A.; Mosca, A.; Teodori, L.; Tomassone, L.; Grego, E.; Monaco, F.; Lorusso, A.; Savini, G. Further Circulation of West Nile and Usutu Viruses in Wild Birds in Italy. Infect. Genet. Evol. 2015, 32, 292–297. [Google Scholar] [CrossRef]
  2. Marini, G.; Rosà, R.; Pugliese, A.; Rizzoli, A.; Rizzo, C.; Russo, F.; Montarsi, F.; Capelli, G. West Nile Virus Transmission and Human Infection Risk in Veneto (Italy): A Modelling Analysis. Sci. Rep. 2018, 8, 14005. [Google Scholar] [CrossRef]
  3. Venter, M.; Swanepoel, R. West Nile Virus Lineage 2 as a Cause of Zoonotic Neurological Disease in Humans and Horses in Southern Africa. Vector-Borne Zoonotic Dis. 2010, 10, 659–664. [Google Scholar] [CrossRef] [Green Version]
  4. Pérez-Ramírez, E.; Llorente, F.; Del Amo, J.; Fall, G.; Lubisi, A.; Lecollinet, S.; Vázquez, A.; Jiménez-Clavero, M.Á. Pathogenicity Evaluation of Twelve West Nile Virus Strains Belonging to Four Lineages from Five Continents in a Mouse Model: Discrimination between Three Pathogenicity Categories. J. Gen. Virol. 2017, 98, 662–670. [Google Scholar] [CrossRef] [PubMed]
  5. Beck, C.; Jimenez-Clavero, M.A.; Leblond, A.; Durand, B.; Nowotny, N.; Leparc-Goffart, I.; Zientara, S.; Jourdain, E.; Lecollinet, S. Flaviviruses in Europe: Complex Circulation Patterns and Their Consequences for the Diagnosis and Control of West Nile Disease. Int. J. Environ. Res. Public Health 2013, 10, 6049–6083. [Google Scholar] [CrossRef] [Green Version]
  6. Epidemiological History and Phylogeography of West Nile Virus Lineage 2—Abstract—Europe PMC. Available online: https://europepmc.org/article/med/23542457 (accessed on 22 June 2020).
  7. Fall, G.; Di Paola, N.; Faye, M.; Dia, M.; Freire, C.C.d.M.; Loucoubar, C.; Zanotto, P.M.d.A.; Faye, O.; Sall, A.A. Biological and Phylogenetic Characteristics of West African Lineages of West Nile Virus. PLoS Negl. Trop. Dis. 2017, 11, e0006078. [Google Scholar] [CrossRef]
  8. Beck, C.; Leparc Goffart, I.; Franke, F.; Gonzalez, G.; Dumarest, M.; Lowenski, S.; Blanchard, Y.; Lucas, P.; de Lamballerie, X.; Grard, G.; et al. Contrasted Epidemiological Patterns of West Nile Virus Lineages 1 and 2 Infections in France from 2015 to 2019. Pathogens 2020, 9, 908. [Google Scholar] [CrossRef] [PubMed]
  9. Filipe, A.R.; Pinto, M.R. Survey for Antibodies to Arboviruses in Serum of Animals from Southern Portugal. Am. J. Trop. Med. Hyg. 1969, 18, 423–426. [Google Scholar] [CrossRef] [PubMed]
  10. Joubert, L.; Oudar, J.; Hannoun, C.; Beytout, D.; Corniou, B.; Guillon, J.C.; Panthier, R. Epidemiology of the West Nile virus: Study of a focus in Camargue. IV. Meningo-encephalomyelitis of the horse. Ann. Inst. Pasteur 1970, 118, 239–247. [Google Scholar]
  11. Malkinson, M.; Banet, C.; Weisman, Y. Intercontinental Spread of West Nile Virus by Wild Birds—Recent Epidemiological Findings in Israeli Livestock and Birds. In Proceedings of the 2nd International Conference on Emerging Zoonoses, Strasbourg, France, 5–9 November 1998; Volume 2. [Google Scholar]
  12. Cantile, C.; Di Guardo, G.; Eleni, C.; Arispici, M. Clinical and Neuropathological Features of West Nile Virus Equine Encephalomyelitis in Italy. Equine Vet. J. 2000, 32, 31–35. [Google Scholar] [CrossRef] [PubMed]
  13. Autorino, G.L.; Battisti, A.; Deubel, V.; Ferrari, G.; Forletta, R.; Giovannini, A.; Lelli, R.; Murri, S.; Scicluna, M.T. West Nile Virus Epidemic in Horses, Tuscany Region, Italy. Emerg. Infect. Dis. 2002, 8, 1372–1378. [Google Scholar] [CrossRef] [PubMed]
  14. Murgue, B.; Murri, S.; Triki, H.; Deubel, V.; Zeller, H.G. West Nile in the Mediterranean Basin: 1950–2000. Ann. N. Y. Acad. Sci. 2001, 951, 117–126. [Google Scholar] [CrossRef]
  15. Steinman, A.; Banet, C.; Sutton, G.A.; Yadin, H.; Hadar, S.; Brill, A. Clinical Signs of West Nile Virus Encephalomyelitis in Horses during the Outbreak in Israel in 2000. Vet. Rec. 2002, 151, 47–49. [Google Scholar] [CrossRef]
  16. Schuffenecker, I.; Peyrefitte, C.N.; el Harrak, M.; Murri, S.; Leblond, A.; Zeller, H.G. West Nile Virus in Morocco, 2003. Emerg. Infect. Dis. 2005, 11, 306–309. [Google Scholar] [CrossRef]
  17. Cernescu, C.; Nedelcu, N.-I.; Tardei, G.; Ruta, S.; Tsai, T.F. Continued Transmission of West Nile Virus to Humans in Southeastern Romania, 1997–1998. J. Infect. Dis. 2000, 181, 710–712. [Google Scholar] [CrossRef]
  18. Platonov, A.E.; Shipulin, G.A.; Shipulina, O.Y.; Tyutyunnik, E.N.; Frolochkina, T.I.; Lanciotti, R.S.; Yazyshina, S.; Platonova, O.V.; Obukhov, I.L.; Zhukov, A.N.; et al. Outbreak of West Nile Virus Infection, Volgograd Region, Russia, 1999. Emerg. Infect. Dis. 2001, 7, 128–132. [Google Scholar] [CrossRef]
  19. Ceianu, C.S.; Ungureanu, A.; Nicolescu, G.; Cernescu, C.; Nitescu, L.; Tardei, G.; Petrescu, A.; Pitigoi, D.; Martin, D.; Ciulacu-Purcarea, V. West Nile Virus Surveillance in Romania: 1997–2000. Viral Immunol. 2001, 14, 251–262. [Google Scholar] [CrossRef] [PubMed]
  20. Charrel, R.N.; Brault, A.C.; Gallian, P.; Lemasson, J.-J.; Murgue, B.; Murri, S.; Pastorino, B.; Zeller, H.; de Chesse, R.; de Micco, P.; et al. Evolutionary Relationship between Old World West Nile Virus Strains. Evidence for Viral Gene Flow between Africa, the Middle East, and Europe. Virology 2003, 315, 381–388. [Google Scholar] [CrossRef] [Green Version]
  21. Campbell, G.L.; Ceianu, C.S.; Savage, H.M. Epidemic West Nile Encephalitis in Romania: Waiting for History to Repeat Itself. Ann. N. Y. Acad. Sci. 2001, 951, 94–101. [Google Scholar] [CrossRef] [PubMed]
  22. Del Giudice, P.; Schuffenecker, I.; Vandenbos, F.; Counillon, E.; Zellet, H. Human West Nile Virus, France. Emerg. Infect. Dis. 2004, 10, 1885–1886. [Google Scholar] [CrossRef]
  23. Johnson, N.; Fernández de Marco, M.; Giovannini, A.; Ippoliti, C.; Danzetta, M.L.; Svartz, G.; Erster, O.; Groschup, M.H.; Ziegler, U.; Mirazimi, A.; et al. Emerging Mosquito-Borne Threats and the Response from European and Eastern Mediterranean Countries. Int. J. Environ. Res. Public Health 2018, 15, 2775. [Google Scholar] [CrossRef] [Green Version]
  24. Bakonyi, T.; Ivanics, É.; Erdélyi, K.; Ursu, K.; Ferenczi, E.; Weissenböck, H.; Nowotny, N. Lineage 1 and 2 Strains of Encephalitic West Nile Virus, Central Europe. Emerg. Infect. Dis. 2006, 12, 618–623. [Google Scholar] [CrossRef] [PubMed]
  25. Bakonyi, T.; Ferenczi, E.; Erdélyi, K.; Kutasi, O.; Csörgő, T.; Seidel, B.; Weissenböck, H.; Brugger, K.; Bán, E.; Nowotny, N. Explosive Spread of a Neuroinvasive Lineage 2 West Nile Virus in Central Europe, 2008/2009. Vet. Microbiol. 2013, 165, 61–70. [Google Scholar] [CrossRef]
  26. Papa, A.; Danis, K.; Baka, A.; Bakas, A.; Dougas, G.; Lytras, T.; Theocharopoulos, G.; Chrysagis, D.; Vassiliadou, E.; Kamaria, F.; et al. Ongoing Outbreak of West Nile Virus Infections in Humans in Greece, July–August 2010. Eurosurveillance 2010, 15, 19644. [Google Scholar] [CrossRef] [PubMed]
  27. Napp, S.; Petrić, D.; Busquets, N. West Nile Virus and Other Mosquito-Borne Viruses Present in Eastern Europe. Pathog. Glob. Health 2018, 112, 233–248. [Google Scholar] [CrossRef]
  28. Merdić, E.; Perić, L.; Pandak, N.; Kurolt, I.C.; Turić, N.; Vignjević, G.; Stolfa, I.; Milas, J.; Bogojević, M.S.; Markotić, A. West Nile Virus Outbreak in Humans in Croatia, 2012. Coll. Antropol. 2013, 37, 943–947. [Google Scholar]
  29. Savini, G.; Capelli, G.; Monaco, F.; Polci, A.; Russo, F.; Di Gennaro, A.; Marini, V.; Teodori, L.; Montarsi, F.; Pinoni, C.; et al. Evidence of West Nile Virus Lineage 2 Circulation in Northern Italy. Vet. Microbiol. 2012, 158, 267–273. [Google Scholar] [CrossRef]
  30. De Heus, P.; Kolodziejek, J.; Camp, J.V.; Dimmel, K.; Bagó, Z.; Hubálek, Z.; van den Hoven, R.; Cavalleri, J.-M.V.; Nowotny, N. Emergence of West Nile Virus Lineage 2 in Europe: Characteristics of the First Seven Cases of West Nile Neuroinvasive Disease in Horses in Austria. Transbound. Emerg. Dis. 2020, 67, 1189–1197. [Google Scholar] [CrossRef]
  31. Magurano, F.; Remoli, M.E.; Baggieri, M.; Fortuna, C.; Marchi, A.; Fiorentini, C.; Bucci, P.; Benedetti, E.; Ciufolini, M.G.; Rizzo, C.; et al. Circulation of West Nile Virus Lineage 1 and 2 during an Outbreak in Italy. Clin. Microbiol. Infect. 2012, 18, E545–E547. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Rizzo, C.; Napoli, C.; Venturi, G.; Pupella, S.; Lombardini, L.; Calistri, P.; Monaco, F.; Cagarelli, R.; Angelini, P.; Bellini, R.; et al. West Nile Virus Transmission: Results from the Integrated Surveillance System in Italy, 2008 to 2015. Eurosurveillance 2016, 21, 30340. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Zehender, G.; Veo, C.; Ebranati, E.; Carta, V.; Rovida, F.; Percivalle, E.; Moreno, A.; Lelli, D.; Calzolari, M.; Lavazza, A.; et al. Reconstructing the Recent West Nile Virus Lineage 2 Epidemic in Europe and Italy Using Discrete and Continuous Phylogeography. PLoS ONE 2017, 12, e0179679. [Google Scholar] [CrossRef] [Green Version]
  34. Vázquez, A.; Sánchez-Seco, M.P.; Ruiz, S.; Molero, F.; Hernández, L.; Moreno, J.; Magallanes, A.; Tejedor, C.G.; Tenorio, A. Putative New Lineage of West Nile Virus, Spain. Emerg. Infect. Dis. 2010, 16, 549–552. [Google Scholar] [CrossRef] [PubMed]
  35. Martín-Acebes, M.A.; Saiz, J.-C. West Nile Virus: A Re-Emerging Pathogen Revisited. World J. Virol. 2012, 1, 51–70. [Google Scholar] [CrossRef] [PubMed]
  36. Benjelloun, A.; El Harrak, M.; Calistri, P.; Loutfi, C.; Kabbaj, H.; Conte, A.; Ippoliti, C.; Danzetta, M.L.; Belkadi, B. Seroprevalence of West Nile Virus in Horses in Different Moroccan Regions. Vet. Med. Sci. 2017, 3, 198–207. [Google Scholar] [CrossRef] [Green Version]
  37. Amdouni, J.; Monaco, F.; Portanti, O.; Sghaier, S.; Conte, A.; Hassine, T.B.; Polci, A.; Valleriani, F.; Gennaro, A.D.; Zoueri, M.; et al. Detection of Enzootic Circulation of a New Strain of West Nile Virus Lineage 1 in Sentinel Chickens in the North of Tunisia. Acta Trop. 2020, 202, 105223. [Google Scholar] [CrossRef]
  38. Assaid, N.; Mousson, L.; Moutailler, S.; Arich, S.; Akarid, K.; Monier, M.; Beck, C.; Lecollinet, S.; Failloux, A.-B.; Sarih, M. Evidence of Circulation of West Nile Virus in Culex Pipiens Mosquitoes and Horses in Morocco. Acta Trop. 2020, 205, 105414. [Google Scholar] [CrossRef] [PubMed]
  39. Bravo-Barriga, D.; Aguilera-Sepúlveda, P.; Guerrero-Carvajal, F.; Llorente, F.; Reina, D.; Pérez-Martín, J.E.; Jiménez-Clavero, M.Á.; Frontera, E. West Nile and Usutu Virus Infections in Wild Birds Admitted to Rehabilitation Centres in Extremadura, Western Spain, 2017–2019. Vet. Microbiol. 2021, 255, 109020. [Google Scholar] [CrossRef]
  40. Conte, A.; Candeloro, L.; Ippoliti, C.; Monaco, F.; Massis, F.D.; Bruno, R.; Sabatino, D.D.; Danzetta, M.L.; Benjelloun, A.; Belkadi, B.; et al. Spatio-Temporal Identification of Areas Suitable for West Nile Disease in the Mediterranean Basin and Central Europe. PLoS ONE 2015, 10, e0146024. [Google Scholar] [CrossRef]
  41. Cotar, A.I.; Fălcuță, E.; Dinu, S.; Necula, A.; Bîrluțiu, V.; Ceianu, C.S.; Prioteasa, F.L. West Nile Virus Lineage 2 in Romania, 2015–2016: Co-Circulation and Strain Replacement. Parasit. Vectors 2018, 11, 562. [Google Scholar] [CrossRef] [Green Version]
  42. Ozkul, A.; Ergunay, K.; Koysuren, A.; Alkan, F.; Arsava, E.M.; Tezcan, S.; Emekdas, G.; Hacioglu, S.; Turan, M.; Us, D. Concurrent Occurrence of Human and Equine West Nile Virus Infections in Central Anatolia, Turkey: The First Evidence for Circulation of Lineage 1 Viruses. Int. J. Infect. Dis. 2013, 17, e546–e551. [Google Scholar] [CrossRef] [Green Version]
  43. Ergünay, K.; Litzba, N.; Brinkmann, A.; Günay, F.; Sarıkaya, Y.; Kar, S.; Örsten, S.; Öter, K.; Domingo, C.; Erisoz Kasap, Ö.; et al. Co-Circulation of West Nile Virus and Distinct Insect-Specific Flaviviruses in Turkey. Parasit. Vectors 2017, 10, 149. [Google Scholar] [CrossRef] [Green Version]
  44. Richter, J.; Tryfonos, C.; Tourvas, A.; Floridou, D.; Paphitou, N.I.; Christodoulou, C. Complete Genome Sequence of West Nile Virus (WNV) from the First Human Case of Neuroinvasive WNV Infection in Cyprus. Genome Announc. 2017, 5, e01110-17. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  45. López-Ruiz, N.; del Carmen Montaño-Remacha, M.; Durán-Pla, E.; Pérez-Ruiz, M.; Navarro-Marí, J.M.; Salamanca-Rivera, C.; Miranda, B.; Oyonarte-Gómez, S.; Ruiz-Fernández, J. West Nile Virus Outbreak in Humans and Epidemiological Surveillance, West Andalusia, Spain, 2016. Eurosurveillance 2018, 23, 17-00261. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  46. Yıldırım, Y.; Yılmaz, V.; Yazıcı, K.; Öziç, C.; Ozkul, A.; Çağırgan, A.A. Phylogenetic Analysis of West Nile Virus: First Report of Lineage 1 in Donkey in Turkey. Trop. Anim. Health Prod. 2021, 53, 453. [Google Scholar] [CrossRef] [PubMed]
  47. Akıner, M.M.; Öztürk, M.; Başer, A.B.; Günay, F.; Hacıoğlu, S.; Brinkmann, A.; Emanet, N.; Alten, B.; Özkul, A.; Nitsche, A.; et al. Arboviral Screening of Invasive Aedes Species in Northeastern Turkey: West Nile Virus Circulation and Detection of Insect-Only Viruses. PLoS Negl. Trop. Dis. 2019, 13, e0007334. [Google Scholar] [CrossRef]
  48. Lustig, Y.; Gosinov, R.; Zuckerman, N.; Glazer, Y.; Orshan, L.; Sofer, D.; Schwartz, E.; Schvartz, G.; Farnoushi, Y.; Lublin, A.; et al. Epidemiologic and Phylogenetic Analysis of the 2018 West Nile Virus (WNV) Outbreak in Israel Demonstrates Human Infection of WNV Lineage I. Eurosurveillance 2019, 24, 1800662. [Google Scholar] [CrossRef]
  49. Schvartz, G.; Farnoushi, Y.; Berkowitz, A.; Edery, N.; Hahn, S.; Steinman, A.; Lublin, A.; Erster, O. Molecular Characterization of the Re-Emerging West Nile Virus in Avian Species and Equids in Israel, 2018, and Pathological Description of the Disease. Parasit. Vectors 2020, 13, 528. [Google Scholar] [CrossRef]
  50. Petrović, T.; Šekler, M.; Petrić, D.; Vidanović, D.; Debeljak, Z.; Lazić, G.; Lupulović, D.; Kavran, M.; Samojlović, M.; Ignjatović Ćupina, A.; et al. Intensive West Nile Virus Circulation in Serbia in 2018—Results of Integrated Surveillance Program. Pathogens 2021, 10, 1294. [Google Scholar] [CrossRef] [PubMed]
  51. Savini, G.; Monaco, F.; Calistri, P.; Lelli, R. Phylogenetic Analysis of West Nile Virus Isolated in Italy in 2008. Eurosurveillance 2008, 13, 19048. [Google Scholar] [CrossRef] [PubMed]
  52. Monaco, F.; Goffredo, M.; Briguglio, P.; Pinoni, C.; Polci, A.; Iannetti, S.; Marruchella, G.; Di Francesco, G.; Di Gennaro, A.P.; Pais, M.; et al. The 2011 West Nile Disease Outbreak in Sardinia Region, Italy. Vet. Ital. 2015, 51, 5–16. [Google Scholar] [CrossRef]
  53. Monaco, F.; Savini, G.; Calistri, P.; Polci, A.; Pinoni, C.; Bruno, R.; Lelli, R. 2009 West Nile Disease Epidemic in Italy: First Evidence of Overwintering in Western Europe? Res. Vet. Sci. 2011, 91, 321–326. [Google Scholar] [CrossRef]
  54. Paternoster, G.; Tomassone, L.; Tamba, M.; Chiari, M.; Lavazza, A.; Piazzi, M.; Favretto, A.R.; Balduzzi, G.; Pautasso, A.; Vogler, B.R. The Degree of One Health Implementation in the West Nile Virus Integrated Surveillance in Northern Italy, 2016. Front. Public Health 2017, 5, 236. [Google Scholar] [CrossRef] [Green Version]
  55. Calistri, P.; Giovannini, A.; Savini, G.; Monaco, F.; Bonfanti, L.; Ceolin, C.; Terregino, C.; Tamba, M.; Cordioli, P.; Lelli, R. West Nile Virus Transmission in 2008 in North-Eastern Italy. Zoonoses Public Health 2010, 57, 211–219. [Google Scholar] [CrossRef] [PubMed]
  56. Barzon, L.; Pacenti, M.; Franchin, E.; Squarzon, L.; Lavezzo, E.; Toppo, S.; Martello, T.; Cattai, M.; Cusinato, R.; Palù, G. Novel West Nile Virus Lineage 1a Full Genome Sequences from Human Cases of Infection in North-Eastern Italy, 2011. Clin. Microbiol. Infect. 2012, 18, E541–E544. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Barzon, L.; Papa, A.; Lavezzo, E.; Franchin, E.; Pacenti, M.; Sinigaglia, A.; Masi, G.; Trevisan, M.; Squarzon, L.; Toppo, S.; et al. Phylogenetic Characterization of Central/Southern European Lineage 2 West Nile Virus: Analysis of Human Outbreaks in Italy and Greece, 2013–2014. Clin. Microbiol. Infect. 2015, 21, 1122.e1–1122.e10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  58. Bagnarelli, P.; Marinelli, K.; Trotta, D.; Monachetti, A.; Tavio, M.; Del Gobbo, R.; Capobianchi, M.; Menzo, S.; Nicoletti, L.; Magurano, F.; et al. Human Case of Autochthonous West Nile Virus Lineage 2 Infection in Italy, September 2011. Eurosurveillance 2011, 16, 20002. [Google Scholar] [CrossRef]
  59. Barzon, L.; Pacenti, M.; Franchin, E.; Squarzon, L.; Lavezzo, E.; Cattai, M.; Cusinato, R.; Palù, G. The Complex Epidemiological Scenario of West Nile Virus in Italy. Int. J. Environ. Res. Public Health 2013, 10, 4669–4689. [Google Scholar] [CrossRef] [Green Version]
  60. Del Amo, J.; Sotelo, E.; Fernández-Pinero, J.; Gallardo, C.; Llorente, F.; Agüero, M.; Jiménez-Clavero, M.A. A Novel Quantitative Multiplex Real-Time RT-PCR for the Simultaneous Detection and Differentiation of West Nile Virus Lineages 1 and 2, and of Usutu Virus. J. Virol. Methods 2013, 189, 321–327. [Google Scholar] [CrossRef]
  61. Vázquez, A.; Herrero, L.; Negredo, A.; Hernández, L.; Sánchez-Seco, M.P.; Tenorio, A. Real Time PCR Assay for Detection of All Known Lineages of West Nile Virus. J. Virol. Methods 2016, 236, 266–270. [Google Scholar] [CrossRef]
  62. Marcacci, M.; De Luca, E.; Zaccaria, G.; Di Tommaso, M.; Mangone, I.; Aste, G.; Savini, G.; Boari, A.; Lorusso, A. Genome Characterization of Feline Morbillivirus from Italy. J. Virol. Methods 2016, 234, 160–163. [Google Scholar] [CrossRef]
  63. Aprea, G.; Scattolini, S.; D’Angelantonio, D.; Chiaverini, A.; Di Lollo, V.; Olivieri, S.; Marcacci, M.; Mangone, I.; Salucci, S.; Antoci, S.; et al. Whole Genome Sequencing Characterization of HEV3-e and HEV3-f Subtypes among the Wild Boar Population in the Abruzzo Region, Italy: First Report. Microorganisms 2020, 8, 1393. [Google Scholar] [CrossRef] [PubMed]
  64. Djikeng, A.; Halpin, R.; Kuzmickas, R.; Depasse, J.; Feldblyum, J.; Sengamalay, N.; Afonso, C.; Zhang, X.; Anderson, N.G.; Ghedin, E.; et al. Viral Genome Sequencing by Random Priming Methods. BMC Genom. 2008, 9, 5. [Google Scholar] [CrossRef] [Green Version]
  65. Bolger, A.M.; Lohse, M.; Usadel, B. Trimmomatic: A Flexible Trimmer for Illumina Sequence Data. Bioinformatics 2014, 30, 2114–2120. [Google Scholar] [CrossRef] [Green Version]
  66. Cito, F.; Pasquale, A.D.; Cammà, C.; Cito, P. The Italian Information System for the Collection and Analysis of Complete Genome Sequence of Pathogens Isolated from Animal, Food and Environment. Int. J. Infect. Dis. 2018, 73, 296–297. [Google Scholar] [CrossRef]
  67. Bankevich, A.; Nurk, S.; Antipov, D.; Gurevich, A.A.; Dvorkin, M.; Kulikov, A.S.; Lesin, V.M.; Nikolenko, S.I.; Pham, S.; Prjibelski, A.D.; et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J. Comput. Biol. J. Comput. Mol. Cell Biol. 2012, 19, 455–477. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  68. Langmead, B.; Salzberg, S.L. Fast Gapped-Read Alignment with Bowtie 2. Nat. Methods 2012, 9, 357–359. [Google Scholar] [CrossRef] [Green Version]
  69. Drummond, A.J.; Suchard, M.A.; Xie, D.; Rambaut, A. Bayesian Phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 2012, 29, 1969–1973. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Price, M.N.; Dehal, P.S.; Arkin, A.P. FastTree 2--Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 2010, 5, e9490. [Google Scholar] [CrossRef] [PubMed]
  71. Sotelo, E.; Fernández-Pinero, J.; Llorente, F.; Vázquez, A.; Moreno, A.; Agüero, M.; Cordioli, P.; Tenorio, A.; Jiménez-Clavero, M.Á. Phylogenetic Relationships of Western Mediterranean West Nile Virus Strains (1996–2010) Using Full-Length Genome Sequences: Single or Multiple Introductions? J. Gen. Virol. 2011, 92, 2512–2522. [Google Scholar] [CrossRef]
  72. Monaco, F.; Lelli, R.; Teodori, L.; Pinoni, C.; Di Gennaro, A.; Polci, A.; Calistri, P.; Savini, G. Re-Emergence of West Nile Virus in Italy. Zoonoses Public Health 2010, 57, 476–486. [Google Scholar] [CrossRef]
  73. Sotelo, E.; Fernandez-Pinero, J.; Llorente, F.; Agüero, M.; Hoefle, U.; Blanco, J.M.; Jiménez-Clavero, M.A. Characterization of West Nile Virus Isolates from Spain: New Insights into the Distinct West Nile Virus Eco-Epidemiology in the Western Mediterranean. Virology 2009, 395, 289–297. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Pesko, K.N.; Ebel, G.D. West Nile Virus Population Genetics and Evolution. Infect. Genet. Evol. 2012, 12, 181–190. [Google Scholar] [CrossRef] [Green Version]
  75. Kobayashi, S.; Kaneko, C.; Kawakami, R.; Hasebe, R.; Sawa, H.; Yoshii, K.; Kariwa, H. Amino Acid 159 of the Envelope Protein Affects Viral Replication and T-Cell Infiltration by West Nile Virus in Intracranial Infection. Sci. Rep. 2020, 10, 7168. [Google Scholar] [CrossRef] [PubMed]
  76. Marfin, A.A.; Petersen, L.R.; Eidson, M.; Miller, J.; Hadler, J.; Farello, C.; Werner, B.; Campbell, G.L.; Layton, M.; Smith, P.; et al. Widespread West Nile Virus Activity, Eastern United States, 2000. Emerg. Infect. Dis. 2001, 7, 730–735. [Google Scholar] [CrossRef] [PubMed]
  77. Banet-Noach, C.; Simanov, L.; Malkinson, M. Direct (Non-Vector) Transmission of West Nile Virus in Geese. Avian Pathol. J. WVPA 2003, 32, 489–494. [Google Scholar] [CrossRef] [PubMed]
  78. Gamino, V.; Höfle, U. Pathology and Tissue Tropism of Natural West Nile Virus Infection in Birds: A Review. Vet. Res. 2013, 44, 39. [Google Scholar] [CrossRef] [Green Version]
  79. Komar, N.; Langevin, S.; Hinten, S.; Nemeth, N.; Edwards, E.; Hettler, D.; Davis, B.; Bowen, R.; Bunning, M. Experimental Infection of North American Birds with the New York 1999 Strain of West Nile Virus. Emerg. Infect. Dis. 2003, 9, 311–322. [Google Scholar] [CrossRef]
  80. Pérez-Ramírez, E.; Llorente, F.; Jiménez-Clavero, M.Á. Experimental Infections of Wild Birds with West Nile Virus. Viruses 2014, 6, 752–781. [Google Scholar] [CrossRef] [Green Version]
  81. Nemeth, N.M.; Kratz, G.E.; Bates, R.; Scherpelz, J.A.; Bowen, R.A.; Komar, N. Clinical Evaluation and Outcomes of Naturally Acquired West Nile Virus Infection in Raptors. J. Zoo Wildl. Med. 2009, 40, 51–63. [Google Scholar] [CrossRef]
  82. Ziegler, U.; Angenvoort, J.; Fischer, D.; Fast, C.; Eiden, M.; Rodriguez, A.V.; Revilla-Fernández, S.; Nowotny, N.; de la Fuente, J.G.; Lierz, M.; et al. Pathogenesis of West Nile Virus Lineage 1 and 2 in Experimentally Infected Large Falcons. Vet. Microbiol. 2013, 161, 263–273. [Google Scholar] [CrossRef]
  83. Vidaña, B.; Busquets, N.; Napp, S.; Pérez-Ramírez, E.; Jiménez-Clavero, M.Á.; Johnson, N. The Role of Birds of Prey in West Nile Virus Epidemiology. Vaccines 2020, 8, 550. [Google Scholar] [CrossRef]
  84. Höfle, U.; Blanco, J.M.; Crespo, E.; Naranjo, V.; Jiménez-Clavero, M.A.; Sanchez, A.; de la Fuente, J.; Gortazar, C. West Nile Virus in the Endangered Spanish Imperial Eagle. Vet. Microbiol. 2008, 129, 171–178. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  85. Jiménez-Clavero, M.A.; Sotelo, E.; Fernandez-Pinero, J.; Llorente, F.; Blanco, J.M.; Rodriguez-Ramos, J.; Perez-Ramirez, E.; Höfle, U. West Nile Virus in Golden Eagles, Spain, 2007. Emerg. Infect. Dis. 2008, 14, 1489–1491. [Google Scholar] [CrossRef] [Green Version]
  86. Garmendia, A.E.; Van Kruiningen, H.J.; French, R.A.; Anderson, J.F.; Andreadis, T.G.; Kumar, A.; West, A.B. Recovery and Identification of West Nile Virus from a Hawk in Winter. J. Clin. Microbiol. 2000, 38, 3110–3111. [Google Scholar] [CrossRef] [Green Version]
  87. Wünschmann, A.; Shivers, J.; Bender, J.; Carroll, L.; Fuller, S.; Saggese, M.; van Wettere, A.; Redig, P. Pathologic Findings in Red-Tailed Hawks (Buteo jamaicensis) and Cooper’s Hawks (Accipiter cooper) Naturally Infected with West Nile Virus. Avian Dis. 2004, 48, 570–580. [Google Scholar] [CrossRef]
  88. Wünschmann, A.; Shivers, J.; Bender, J.; Carroll, L.; Fuller, S.; Saggese, M.; van Wettere, A.; Redig, P. Pathologic and Immunohistochemical Findings in Goshawks (Accipiter gentilis) and Great Horned Owls (Bubo virginianus) Naturally Infected with West Nile Virus. Avian Dis. 2005, 49, 252–259. [Google Scholar] [CrossRef] [PubMed]
  89. Donadieu, E.; Bahuon, C.; Lowenski, S.; Zientara, S.; Coulpier, M.; Lecollinet, S. Differential Virulence and Pathogenesis of West Nile Viruses. Viruses 2013, 5, 2856–2880. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  90. Saiz, J.-C.; Martín-Acebes, M.A.; Blázquez, A.B.; Escribano-Romero, E.; Poderoso, T.; Jiménez de Oya, N. Pathogenicity and Virulence of West Nile Virus Revisited Eight Decades after Its First Isolation. Virulence 2021, 12, 1145–1173. [Google Scholar] [CrossRef]
  91. Gray, R.R.; Veras, N.M.C.; Santos, L.A.; Salemi, M. Evolutionary Characterization of the West Nile Virus Complete Genome. Mol. Phylogenet. Evol. 2010, 56, 195–200. [Google Scholar] [CrossRef]
  92. Fredericksen, B.L.; Smith, M.; Katze, M.G.; Shi, P.-Y.; Gale, M. The Host Response to West Nile Virus Infection Limits Viral Spread through the Activation of the Interferon Regulatory Factor 3 Pathway. J. Virol. 2004, 78, 7737–7747. [Google Scholar] [CrossRef] [Green Version]
  93. Kinney, R.M.; Huang, C.Y.-H.; Whiteman, M.C.; Bowen, R.A.; Langevin, S.A.; Miller, B.R.; Brault, A.C. Avian Virulence and Thermostable Replication of the North American Strain of West Nile Virus. J. Gen. Virol. 2006, 87, 3611–3622. [Google Scholar] [CrossRef] [PubMed]
  94. Brault, A.C.; Huang, C.Y.-H.; Langevin, S.A.; Kinney, R.M.; Bowen, R.A.; Ramey, W.N.; Panella, N.A.; Holmes, E.C.; Powers, A.M.; Miller, B.R. A Single Positively Selected West Nile Viral Mutation Confers Increased Virogenesis in American Crows. Nat. Genet. 2007, 39, 1162–1166. [Google Scholar] [CrossRef] [PubMed]
  95. Montagnaro, S.; Piantedosi, D.; Ciarcia, R.; Loponte, R.; Veneziano, V.; Fusco, G.; Amoroso, M.G.; Ferrara, G.; Damiano, S.; Iovane, G.; et al. Serological Evidence of Mosquito-Borne Flaviviruses Circulation in Hunting Dogs in Campania Region, Italy. Vector-Borne Zoonotic Dis. 2019, 19, 142–147. [Google Scholar] [CrossRef] [PubMed]
Viruses 14 00064 g001 550
Figure 1. Geolocation of sites where the two wild birds were found.
Figure 1. Geolocation of sites where the two wild birds were found.
Viruses 14 00064 g001
Viruses 14 00064 g002 550
Figure 2. Maximum likelihood phylogenetic tree of the WNV complete and partial genome sequences analyzed in this study. Violet, red, and green triangles represent the Mediterranean-Eastern European-Kenyan subtype, the Western Mediterranean subtype, and the Israeli-American subtype of WNV sequences, respectively. The Koutango virus strain EU082200 has been chosen as outgroup. The tree with the highest log-likelihood is shown. The Bayesian phylogenetic analysis was performed through Bayesian Inference (BI) using a general time-reversible with gamma-distributed rate variation, a gamma category count of 4, and an invariant sites model (GTR + Γ + I). The evolutionary distances were computed using the optimal GTR + Γ + I model, with 2000 Γ-rate categories and 5000 bootstrap replications using the Shimodaira–Hasegawa (SH) test. The percentage of successful bootstrap replicate (n5000) is indicated at nodes. A Bayesian MCMC approach using BEAST with JRE v2.6.3 was employed. Ten independent MCMC runs with up to 100 million generations were performed to ensure the convergence of estimates. Tracer v.1.7.1 was used to ensure convergence during MCMC by reaching effective sample sizes greater than 100. Trees were summarized in a maximum clade-credibility tree with common ancestor heights after a 10% burn-in using TreeAnnotator v2.6.3.
Figure 2. Maximum likelihood phylogenetic tree of the WNV complete and partial genome sequences analyzed in this study. Violet, red, and green triangles represent the Mediterranean-Eastern European-Kenyan subtype, the Western Mediterranean subtype, and the Israeli-American subtype of WNV sequences, respectively. The Koutango virus strain EU082200 has been chosen as outgroup. The tree with the highest log-likelihood is shown. The Bayesian phylogenetic analysis was performed through Bayesian Inference (BI) using a general time-reversible with gamma-distributed rate variation, a gamma category count of 4, and an invariant sites model (GTR + Γ + I). The evolutionary distances were computed using the optimal GTR + Γ + I model, with 2000 Γ-rate categories and 5000 bootstrap replications using the Shimodaira–Hasegawa (SH) test. The percentage of successful bootstrap replicate (n5000) is indicated at nodes. A Bayesian MCMC approach using BEAST with JRE v2.6.3 was employed. Ten independent MCMC runs with up to 100 million generations were performed to ensure the convergence of estimates. Tracer v.1.7.1 was used to ensure convergence during MCMC by reaching effective sample sizes greater than 100. Trees were summarized in a maximum clade-credibility tree with common ancestor heights after a 10% burn-in using TreeAnnotator v2.6.3.
Viruses 14 00064 g002
Viruses 14 00064 g003 550
Figure 3. Maximum likelihood phylogenetic tree of the WNV complete and partial genome sequences analyzed in this study. A detailed version of the phylogenetic tree is shown, showing all the Western Mediterranean WNV sequences. GenBank accession numbers are indicated for each strain, with country, lineage, and year of isolation. The WNV-L1 strain TE_362447_2020, obtained from the goshawk found in the Campania region in October 2020, is highlighted in red. The Koutango virus strain EU082200 has been chosen as outgroup. The tree with the highest log-likelihood is shown. The Bayesian phylogenetic analysis was performed through Bayesian Inference using a general time-reversible with gamma-distributed rate variation, a gamma category count of 4, and an invariant sites model (GTR + Γ + I). The evolutionary distances were computed using the optimal GTR + Γ + I model, with 2000 Γ-rate categories and 5000 bootstrap replications using the Shimodaira–Hasegawa (SH) test. The percentage of successful bootstrap replicate (n5000) is indicated at nodes. A Bayesian MCMC approach using BEAST with JRE v2.6.3 was employed. Ten independent MCMC runs with up to 100 million generations were performed to ensure the convergence of estimates. Tracer v.1.7.1 was used to ensure convergence during MCMC by reaching effective sample sizes greater than 100. Trees were summarized in a maximum clade-credibility tree with common ancestor heights after a 10% burn-in using TreeAnnotator v2.6.3.
Figure 3. Maximum likelihood phylogenetic tree of the WNV complete and partial genome sequences analyzed in this study. A detailed version of the phylogenetic tree is shown, showing all the Western Mediterranean WNV sequences. GenBank accession numbers are indicated for each strain, with country, lineage, and year of isolation. The WNV-L1 strain TE_362447_2020, obtained from the goshawk found in the Campania region in October 2020, is highlighted in red. The Koutango virus strain EU082200 has been chosen as outgroup. The tree with the highest log-likelihood is shown. The Bayesian phylogenetic analysis was performed through Bayesian Inference using a general time-reversible with gamma-distributed rate variation, a gamma category count of 4, and an invariant sites model (GTR + Γ + I). The evolutionary distances were computed using the optimal GTR + Γ + I model, with 2000 Γ-rate categories and 5000 bootstrap replications using the Shimodaira–Hasegawa (SH) test. The percentage of successful bootstrap replicate (n5000) is indicated at nodes. A Bayesian MCMC approach using BEAST with JRE v2.6.3 was employed. Ten independent MCMC runs with up to 100 million generations were performed to ensure the convergence of estimates. Tracer v.1.7.1 was used to ensure convergence during MCMC by reaching effective sample sizes greater than 100. Trees were summarized in a maximum clade-credibility tree with common ancestor heights after a 10% burn-in using TreeAnnotator v2.6.3.
Viruses 14 00064 g003
Table
Table 1. Relevant data regarding the isolates used for the present study.
Table 1. Relevant data regarding the isolates used for the present study.
Strain NumberViral SpeciesIsolation MaterialHostCountryYear of IsolationAccession Number
TE.362447.2020WNV L1HomogenateNorthern goshawkItaly2020MW627239
TE.15803.2008WNV L1-MagpieItaly2008FJ483548
TE.15217.2008WNV L1-MagpieItaly2008FJ483549
TE.229892.2008WNV L1-MagpieItaly 2008KU573077
Ita09WNV L1BloodHumanItaly2009GU011992
Italy/2009/J-225677WNV L1C636 cells P1, Vero cells P3Eurasian jayItaly2009JF719068
Italy/2009/FINWNV L1-HumanItaly2009KF234080
Italy/2008/J-242853WNV L1C636 cells P1, Vero cells P3Eurasian jayItaly2008JF719065
Italy/2009/G-223184WNV L1C636 cells P1, Vero cells P3GullItaly2009JF719067
Italy/2008/M-203204WNV L1C636 cells P1, Vero cells P3MagpieItaly2008JF719066
204913/2009WNV L1-Culex pipiens mosquitoItaly2009KU573078
TE.14444.2011WNV L1Organ poolMagpieItaly2011MW835356
TE.17196.2011WNV L1Organ poolOwlItaly2011MW835357
TE.17208.2011WNV L1Organ poolCrowItaly2011MW835358
TE.20224/1.2011WNV L1PlasmaChickenItaly2011MW835359
TE.21370.2011WNV L1PlasmaHorseItaly2011MW835361
TE.20875.2011WNV L1Organ poolEurasian jayItaly2011MW835360
TE.23237.2011WNV L1PlasmaChickenItaly2011MW835363
TE.20224/8.2011WNV L1PlasmaChickenItaly2011Under publication
TE.21412.2011WNV L1BrainOwlItaly2011MW835362
04.05WNV L1BrainHorseMorocco2003AY701413
PT5.2WNV L1--Portugal2004AJ965628
PT6.16WNV L1--Portugal2009AJ965626
Spain/2010/H-1bWNV L1BrainHorseSpain2010JF719069
WN Italy 1998-equineWNV L1-EquineItaly1998AF404757
96-111WNV L1BrainEquineMorocco1996AY701412
PaAn001WNV L1--France2003AY268132
France 405/04WNV L1BrainHouse sparrowFrance2004DQ786572
WNV_0304h_ISR00WNV L1-HumanIsrael2000HM152775
GE-2o/VWNV L1Vero cellsGolden eagleSpain2007FJ766332
GE-1b/BWNV L1BSR cellsGolden eagleIsrael2007FJ766331
HU6365/08WNV L1-Culex perexiguus mosquitoSpain2008JF707789
RO97-50WNV L1-Culex pipiens mosquitoRomania1996AF260969
KN3829WNV L1-Culex univittatus mosquitoUSA2003AY262283
VLG-4WNV L1BrainHumanRussia1999AF317203
Tomsk/bird/2006/A4WNV L1-Blyth’s reed warblerRussia2006MN149538
LEIV-Vlg99-27889WNV L1BrainHumanRussia1999AY277252
LEIV-Vlg00-27924WNV L1BloodHumanRussia2000AY278442
Italy/2012/Livenza/37.1WNV L1UrineHumanItaly2012KC954092
Italy/2012/Livenza/31.1WNV L1Culture viral isolate from bloodHumanItaly2012JX556213
Italy/2013/Livenza/35.1WNV L1PlasmaHumanItaly2013KF647253
Italy/2011/LivenzaWNV L1PlasmaHumanItaly2011JQ928174
Italy/2013/Livenza/37.1WNV L1UrineHumanItaly2013KF823807
Akela/France/2015WNV L1-HumanFrance2015MT863559
Italy/2011/AN-1WNV L1UrineHumanItaly2011JN858069
Italy/2011/PiaveWNV L1UrineHumanItaly2011JQ928175
WNV_Cy2016WNV L1UrineHumanCyprus2016MF797870
T2WNV L1BloodEquineTurkey 2011KJ958922
ArB310/67WNV L1--Central African Republic1967GQ851608
IBAN7019WNV L1--Nigeria1965GQ851607
ArD27875WNV L1-MosquitoSenegal 1979GQ851606
PaH001WNV L1--France2003AY268133
NY99-flamingo382-99WNV L1Chicken embryoFlamingoUSA1999AF196835
ABB-B13WNV L1-MouseSpain2007KC407667
NY99WNV L1Vero cell P2-USA1999NC009942
NY99iso-1WNV L1Vero cell E6 -Japan2007FJ411043
NY99-crow-V76/1WNV L1-American crowUSA1999FJ151394
3356K VP2WNV L1KidneyAmerican crowUSA2000EF657887
WNV-1/US/BID-V6527/2001WNV L1Kidney and SpleenAmerican crowUSA2001KJ501343
WNV-1/US/BID-V6506/2002WNV L1Kidney and SpleenAmerican crowUSA2002KJ501489
Ast99-901WNV L1BloodHumanRussia1999AY278441
KN3829WNV L1-Culex univittatus mosquitoKenya1998AF146082
RO97-50WNV L1--Romania1997AF130362
SEN-ArD93548WNV L1-MosquitoSenegal1993AF001570
Dak Ar D 5443KOUTANGO VIRUS--Senegal2013EU082200
Relevant data regarding the isolates used for the present study.
Table
Table 2. Amino acid sequence comparison of MW627239 (goshawk, Italy, 2020) and representative WNV-L1 Italian, European, and American strains, conducted using BioEdit v. 7.2 software. The strains (i) 115803 (accession number: FJ483548, Italy, 2008); (ii) WNV Italy 1998-equine (accession number: AF404757, Italy, 1998); (iii) Italy/2008/M-203204 (accession number: JF719066, Italy, 2008); (iv) Italy/2008/J-242853 (accession number: JF719065, Italy, 2008); (v) 21412 (accession number: MW835362, Italy, 2011); (vi) Italy/2013/Livenza/35.1 (accession number: KF647253, Italy, 2013); (vii) Spain/2010/H-1b (accession number: JF719069, Spain, 2010); (viii) GE-2o/V (accession number: FJ766332, Spain, 2007); (ix) Akela/France/2015 (accession number: MT863559, France, 2015); and (x) NY99 (accession number: NC009942, USA, 1999) were included in the analysis. Only representative amino acid residues were analyzed. C protein: amino acid (aa) 1–105; PreM protein: aa 124–290; M protein: aa 216–290; E protein: aa 291–791; NS1 protein: aa 792–1143; NS2A protein: 1114–1374; NS2B protein: 1375–1505; NS3 protein: 1506–2124; NS4A protein: 2125–2250; NS4B protein: 2274–2528; NS5 protein: 2529–3433. Significant amino acid residue substitutions are highlighted in red.
Table 2. Amino acid sequence comparison of MW627239 (goshawk, Italy, 2020) and representative WNV-L1 Italian, European, and American strains, conducted using BioEdit v. 7.2 software. The strains (i) 115803 (accession number: FJ483548, Italy, 2008); (ii) WNV Italy 1998-equine (accession number: AF404757, Italy, 1998); (iii) Italy/2008/M-203204 (accession number: JF719066, Italy, 2008); (iv) Italy/2008/J-242853 (accession number: JF719065, Italy, 2008); (v) 21412 (accession number: MW835362, Italy, 2011); (vi) Italy/2013/Livenza/35.1 (accession number: KF647253, Italy, 2013); (vii) Spain/2010/H-1b (accession number: JF719069, Spain, 2010); (viii) GE-2o/V (accession number: FJ766332, Spain, 2007); (ix) Akela/France/2015 (accession number: MT863559, France, 2015); and (x) NY99 (accession number: NC009942, USA, 1999) were included in the analysis. Only representative amino acid residues were analyzed. C protein: amino acid (aa) 1–105; PreM protein: aa 124–290; M protein: aa 216–290; E protein: aa 291–791; NS1 protein: aa 792–1143; NS2A protein: 1114–1374; NS2B protein: 1375–1505; NS3 protein: 1506–2124; NS4A protein: 2125–2250; NS4B protein: 2274–2528; NS5 protein: 2529–3433. Significant amino acid residue substitutions are highlighted in red.
Viral ProteinAmino Acid
Position		MW627239 ITA 2020AF404757 ITA 1998 JF719066 ITA 2008 FJ766332 SPA 2007 JF719065 ITA 2008FJ483548 ITA 2008MW835362 ITA 2011KF647253 ITA 2013 NC_009942 USA 1999JF719069 SPA 2010MT863559 FRA 2015
C34MMMVMMMMMMM
100SSSSSSSSSSS
prM72SSSSSSSSSSS
M36IIIIIIIIIII
E 35SSSSSSSSSSS
51TAATAAAAAAA
76TTTTTTTTTTT
88PPPSPPPPPPP
126TTTTTTTTITT
153GGGGGGGGGGG
159IIIIIIIIVII
278TTTTTTTTTTT
312LLLLLLLLLLL
442VVVVVVVVVVV
NS117SSSSSSSSSSS
35YYYHYYYYYYY
45IIIIIIIIIII
70SSSSSSSSASS
94EEEEEEEEEEE
138PPPPPPPPPPP
141KKKKKKKKKKK
188VVVVVVVVVVV
208DDDHDDDDDDD
288SSSSSSSSSSS
289EEEGEEEEEEE
NS2A85IIVIVVIIIII
104NNNNNNNNNNN
119HHHHHHHHHHH
128EEEEEEEEEEE
138VVVVVVVVVVV
165GGGGGGGGGGG
NS2B82DDDDDDDDDDD
83GGGGGGGGGGG
103AAAAAAAVVAA
120VIVVVIVVVVV
NS346FFFFFFFFFFF
244QQQQQQQQQQH
249TTTPTPTPPTT
356IIIIIIIITII
496LLLLLLLLLLL
503NNNNNNNNNNN
521DDDDDDDDDDD
NS4A85VVIVIIVVAVV
100PPSPSSPPPPP
122PPPPPPPPPPP
NS553HHHHHHHHHHH
54PPPPPPPPPPP
257DDDDDDDDDDD
258VVAVAAAVVVV
280KKKKKKKKKKK
372VVVVVVVVVVV
374YYYYYYYYYYY
422RRKRKKKRRRR
426EEEAEEEEEEE
436MMMIMMMMMMM
526TTTTTTTTTTT
653FFFFFFFFFFF
681TTTTTTTTTTT
Table
Table 3. Nucleotide versus amino acid similarities of representative WNV Italian, European, and American strains. Pairwise identity analyses have been conducted among MW627239 and other WNV L-1 Italian, European, and American sequences, using Blast. Among the Italian representative sequences belonging to the WNV-1 WMed single monophyletic group in the maximum-likelihood tree, the average nucleotide and amino acid pairwise identity was evidenced to be 98.13% (s.d. = 0.36) and 99.73% (s.d = 0.07), respectively.
Table 3. Nucleotide versus amino acid similarities of representative WNV Italian, European, and American strains. Pairwise identity analyses have been conducted among MW627239 and other WNV L-1 Italian, European, and American sequences, using Blast. Among the Italian representative sequences belonging to the WNV-1 WMed single monophyletic group in the maximum-likelihood tree, the average nucleotide and amino acid pairwise identity was evidenced to be 98.13% (s.d. = 0.36) and 99.73% (s.d = 0.07), respectively.
MW627239 ITA 2020AF404757 ITA 1998JF719066 ITA 2008JF719065 ITA 2008FJ483548 ITA 2008MW835362 ITA 2011KF647253 ITA 2013NC_009942 USA 1999FJ766332 SPA 2007JF719069 SPA 2010
MW627239 ITA 2020-98.5%98.31%98.33%98.33%98.02%97.67%95.80%97.96%98.27%
AF404757 ITA 199899.85%-98.50%98.53%98.55%98.18%98.54%96.44%98.93%98.51%
JF719066 ITA 200899.68%99.77%-99.95%99.41%98.93%98.13%96.04%98.37%98.75%
JF719065 ITA 200899.71%99.80%99.91%-99.94%98.95%98.15%96.07%98.41%98.78%
FJ483548 ITA 200899.68%99.83%99.88%99.91%-98.93%98.15%96.10%98.39%98.76%
MW835362 ITA 201199.68%99.77%99.71%99.74%99.71%-97.85%95.76%98.00%98.43%
KF647253 ITA 201399.74%99.83%99.65%99.68%99.71%99.65%-96.03%98.34%98.11%
NC_009942 USA 199999.62%99.71%99.56%99.59%99.62%99.53%99.71%-96.29%96.16%
FJ766332 SPA 200799.65%99.68%99.50%99.53%99.56%98.75%99.62%99.50%-98.35%
JF719069 SPA 201099.65%99.74%99.56%99.59%99.56%99.39%99.62%99.50%99.48%-
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mencattelli, G.; Iapaolo, F.; Monaco, F.; Fusco, G.; de Martinis, C.; Portanti, O.; Di Gennaro, A.; Curini, V.; Polci, A.; Berjaoui, S.; et al. West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain? Viruses 2022, 14, 64. https://doi.org/10.3390/v14010064

AMA Style

Mencattelli G, Iapaolo F, Monaco F, Fusco G, de Martinis C, Portanti O, Di Gennaro A, Curini V, Polci A, Berjaoui S, et al. West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain? Viruses. 2022; 14(1):64. https://doi.org/10.3390/v14010064

Chicago/Turabian Style

Mencattelli, Giulia, Federica Iapaolo, Federica Monaco, Giovanna Fusco, Claudio de Martinis, Ottavio Portanti, Annapia Di Gennaro, Valentina Curini, Andrea Polci, Shadia Berjaoui, and et al. 2022. "West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain?" Viruses 14, no. 1: 64. https://doi.org/10.3390/v14010064

APA Style

Mencattelli, G., Iapaolo, F., Monaco, F., Fusco, G., de Martinis, C., Portanti, O., Di Gennaro, A., Curini, V., Polci, A., Berjaoui, S., Di Felice, E., Rosà, R., Rizzoli, A., & Savini, G. (2022). West Nile Virus Lineage 1 in Italy: Newly Introduced or a Re-Occurrence of a Previously Circulating Strain? Viruses, 14(1), 64. https://doi.org/10.3390/v14010064

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop